Organovo Granted U.S. Patent #11789011 Today For "Engineered Three-Dimensional Breast Tissue Adipose And Tumor Disease Model" Background P1: "Models Disclosed Herein Have Several Advantages Over Current Screening Tools"
Portfolio Pulse from Benzinga Newsdesk
Organovo has been granted U.S. Patent #11789011 for an 'Engineered Three-Dimensional Breast Tissue Adipose And Tumor Disease Model'. The patent suggests that the models disclosed have several advantages over current screening tools.
October 17, 2023 | 2:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Organovo's new patent for a 3D breast tissue and tumor disease model could potentially give it a competitive edge in the market.
The granting of a new patent to Organovo for a 3D breast tissue and tumor disease model suggests that the company has developed a potentially superior product. This could give it a competitive advantage in the market, which could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100